Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAR-T Combined With ASCT in R/R Large B-cell Lymphoma With High-risk Factors
NCT07538635Phase 2Recruiting
- Sponsor
- Zhejiang Cancer Hospital
- Start
- Apr 2026
- Primary completion
- Feb 2028
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of axicabtagene ciloleucel in diffuse large B-cell lymphoma (DLBCL), sponsored by Zhejiang Cancer Hospital. Started Apr 2026; status: recruiting.
02
Drugs
axicabtagene ciloleucel
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT07538635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07538635.